The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: Involvement in cell proliferation

Biochemical Journal

Volumn 428, Issue 1, 2010, Pages 113-124

  Jarry, Marie ^a   Diallo, Mickaël ^a   Lecointre, Céline ^a   Desrues, Laurence ^a   Tokay, Tursonjan ^a   Chatenet, David ^a,b   Leprince, Jérôme ^a   Rossi, Oriana ^a   Vaudry, Hubert ^a   Tonon, Marie Christine ^a   Prézeau, Laurent ^c   Castel, Hélène ^a   Gandolfo, Pierrick ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b University of Québec   (Canada)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

Astrocyte; Bioluminescence resonance energy transfer; Calcium; Cell proliferation; G protein; Urotensin II receptor

Indexed keywords

ASTROCYTE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CHANNEL BLOCKERS; CYTOSOLIC; DOSE-DEPENDENT; G PROTEIN; HIGH-AFFINITY BINDING SITES; HIGH-AFFINITY SITES; IN-CELL; INPUT RESISTANCE; LONG LASTING; MECHANISM OF ACTION; MEMBRANE DEPOLARIZATION; MIBEFRADIL; MITOGENIC ACTIVITY; NEUROPEPTIDES; PERTUSSIS TOXIN; PHOSPHOLIPASE C;

BINDING ENERGY; BINDING SITES; BIOCHEMISTRY; BIOLUMINESCENCE; CELL PROLIFERATION; ENERGY TRANSFER; PEPTIDES; PHOSPHORESCENCE; RESONANCE; SUGARS;

CALCIUM;

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 AMINOETHOXYDIPHENYLBORANE; CALCIUM ION; DIAZEPAM BINDING INHIBITOR; EGTAZIC ACID; INOSITOL; IODINE 125; MIBEFRADIL; NEUROPEPTIDE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITIDE; TRITIUM; UNCLASSIFIED DRUG; UROTENSIN II; UROTENSIN II RELATED PEPTIDE; PEPTIDE HORMONE; UROTENSIN; UROTENSIN II RELATED PEPTIDE, RAT; UROTENSIN II-RELATED PEPTIDE, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BINDING AFFINITY; BINDING SITE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL ACTIVITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; EMBRYO; EVOKED RESPONSE; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MITOGENESIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; AMINO ACID SEQUENCE; ANIMAL; METABOLISM;

AMINO ACID SEQUENCE; ANIMALS; ASTROCYTES; CELL PROLIFERATION; PEPTIDE HORMONES; RATS; UROTENSINS;

EID: 77953393621     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090867     Document Type: Article

References (59)

1. Pearson, D., Shively, J. E., Clark, B. R., Geschwind, I. I., Barkley, M., Nishioka, R. S. and Bern, H. A. (1980) Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc. Natl. Acad. Sci. U.S.A. 77, 5021-5024
2. Douglas, S. A. and Ohlstein, E. H. (2000) Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc. Med. 10, 229-237
3. Sugo, T., Murakami, Y., Shimomura, Y., Harada, M., Abe, M., Ishibashi, Y., Kitada, C., Miyajima, N., Suzuki, N., Mori, M. and Fujino, M. (2003) Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem. Biophys. Res. Commun. 310, 860-868
4. Leprince, J., Chatenet, D., Dubessy, C., Fournier, A., Pfeiffer, B., Scalbert, E., Renard, P., Pacaud, P., Oulyadi, H., Ségalas-Milazzo, I. et al. (2008) Structure-activity relationships of urotensin II and URP. Peptides 29, 658-673
5. Tostivint, H., Joly, L., Lihrmann, I., Parmentier, C., Lebon, A., Morisson, M., Calas, A., Ekker, M. and Vaudry, H. (2006) Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc. Natl. Acad. Sci. U.S.A. 103, 2237-2242
6. Coulouarn, Y., Fernex, C., Jégou, S., Henderson, C. E., Vaudry, H. and Lihrmann, I. (2001) Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord. Mech. Dev. 101, 187-190
7. Dun, S. L., Brailoiu, G. C., Yang, J., Chang, J. K. and Dun, N. J. (2001) Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci. Lett. 305, 9-12
8. Sugo, T. and Mori, M. (2008) Another ligand fishing for G protein-coupled receptor 14: discovery of urotensin II-related peptide in the rat brain. Peptides 29, 809-812 (Pubitemid 351522358)
9. Ames, R. S., Sarau, H. M., Chambers, J. K., Willette, R. N., Aiyar, N. V., Romanic, A. M., Louden, C. S., Foley, J. J., Sauermelch, C. F., Coatney, R. W. et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401, 282-286
10. Ziltener, P., Mueller, C., Haenig, B., Scherz, M. W. and Nayler, O. (2002) Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines. J. Recept. Signal Transduction Res. 22, 155-168
11. Sauzeau, V., Le Mellionnec, E., Bertoglio, J., Scalbert, E., Pacaud, P. and Loirand, G. (2001) Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ. Res. 88, 1102-1104
12. Liu, Q., Pong, S. S., Zeng, Z., Zhang, Q., Howard, A. D., Williams, Jr, D. L., Davidoff, M., Wang, R., Austin, C. P., McDonald, T. P. et al. (1999) Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem. Biophys. Res. Commun. 266, 174-178
13. Jégou, S., Cartier, D., Dubessy, C., Gonzalez, B. J., Chatenet, D., Tostivint, H., Scalbert, E., Leprince, J., Vaudry, H. and Lihrmann, I. (2006) Localization of the urotensin II receptor in the rat central nervous system. J. Comp. Neurol. 495, 21-36
14. Do Rego, J. C., Leprince, J., Scalbert, E., Vaudry, H. and Costentin, J. (2008) Behavioral actions of urotensin-II. Peptides 29, 838-844
15. Nothacker, H. P. and Clark, S. (2005) From heart to mind: the urotensin II system and its evolving neurophysiological role. FEBS J. 272, 5694-5702
16. Volterra, A. and Meldolesi, J. (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6, 626-640
17. Guidotti, A., Forchetti, C. M., Corda, M. G., Konkel, D., Bennett, C. D. and Costa, E. (1983) Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl. Acad. Sci. U.S.A. 80, 3531-3535
18. 3H]thymidine incorporation in cultured rat astrocytes. Neuropharmacology 38, 725-732
19. Masmoudi, O., Gandolfo, P., Leprince, J., Vaudry, D., Fournier, A., Patte-Mensah, C., Vaudry, H. and Tonon, M. C. (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. FASEB J. 17, 17-27
20. Masmoudi, O., Gandolfo, P., Tokay, T., Leprince, J., Ravni, A., Vaudry, H. and Tonon, M. C. (2005) Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. J. Neurochem. 94, 561-571
21. Takahashi, K., Totsune, K., Murakami, O. and Shibahara, S. (2001) Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 22, 1175-1179
22. Castel, H., Diallo, M., Chatenet, D., Leprince, J., Desrues, L., Schouft, M. T., Fontaine, M., Dubessy, C., Lihrmann, I., Scalbert, E. et al. (2006) Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J. Neurochem. 99, 582-595
23. Lin, Y., Tsuchihashi, T., Matsumura, K., Fukuhara, M., Ohya, Y., Fujii, K. and Iida, M. (2003) Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertens. Res. 26, 839-845
24. Desrues, L., Lefebvre, T., Diallo, M., Gandolfo, P., Leprince, J., Chatenet, D., Vaudry, H., Tonon, M. C. and Castel, H. (2008) Effect of GABAA receptor activation on UT-coupled signaling pathways in rat cortical astrocytes. Peptides 29, 727-734
25. Chatenet, D., Dubessy, C., Leprince, J., Boularan, C., Carlier, L., Ségalas-Milazzo, I., Guilhaudis, L., Oulyadi, H., Davoust, D., Scalbert, E. et al. (2004) Structure-activity relationships on structural conformation of a novel urotensin II-related peptide. Peptides 25, 1819-1830
26. Diallo, M., Jarry, M., Desrues, L., Castel, H., Chatenet, D., Leprince, J., Vaudry, H., Tonon, M. C. and Gandolfo, P. (2008) [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes. Peptides 29, 813-819
27. Clozel, M., Binkert, C., Birker-Robaczewska, M., Boukhadra, C., Ding, S. S., Fischli, W., Hess, P., Mathys, B., Morrison, K., Muller, C. et al. (2004) Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J. Pharmacol. Exp. Ther. 311, 204-212
28. Ayoub, M. A., Damian, M., Gespach, C., Ferrandis, E., Lavergne, O., De Wever, O., Baneres, J. L., Pin, J. P. and Prevost, G. P. (2009) Inhibition of heterotrimeric G protein signaling by a small molecule acting on Gα subunit. J. Biol. Chem. 284, 29136-29145
29. Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M. and Jockers, R. (2002) Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 21522-21528
30. i1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol. Pharmacol. 71, 1329-1340
31. Gales, C., Van Durm, J. J., Schaak, S., Pontier, S., Percherancier, Y., Audet, M., Audet, M., Paris, H. and Bouvier, M. (2006) Probing the activating-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat. Struct. Mol. Biol. 13, 778-786
32. Song, W., McDonald, J., Camarda, V., Calo, G., Guerrini, R., Marzola, E., Thompson, J. P., Rowbotham, D. J. and Lambert, D. G. (2006) Cell and tissue responses of a range of urotensin II analogs at cloned and native urotensin II receptors: evidence for coupling promiscuity. Naunyn Schmiedebergs Arch. Pharmacol. 373, 148-157
33. Conlon, J. M., Tostivint, H. and Vaudry, H. (1997) Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives. Regul. Pept. 69, 95-103
34. Spier, A. D. and de Lecea, L. (2000) Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain. Res. Rev. 33, 228-241
35. Marchese, A., Heiber, M., Nguyen, T., Heng, H. H., Saldivia, V. R., Cheng, R., Murphy, P. M., Tsui, L. C., Shi, X., Gregor, P. et al. (1995) Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 29, 335-344
36. Nothacker, H. P., Wang, Z., McNeill, A. M., Saito, Y., Merten, S., O'Dowd, B., Duckles, S. P. and Civelli, O. (1999) Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat. Cell Biol. 1, 383-385
37. Feindt, J., Becker, I., Blomer, U., Hugo, H. H., Mehdorn, H. M., Krisch, B. and Mentlein, R. (1995) Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J. Neurochem. 65, 1997-2005
38. Malagon, M. M., Molina, M., Gahete, M. D., Duran-Prado, M., Martinez-Fuentes, A. J., Alcain, F. J., Tonon, M. C., Leprince, J., Vaudry, H., Castano, J. P. and Vazquez-Martinez, R. (2008) Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5. Peptides 29, 711-720
39. Verkhratsky, A. and Steinhäuser, C. (2000) Ion channels in glial cells. Brain Res. Rev. 32, 380-412
40. Clark, S. D., Nothacker, H. P., Blaha, C. D., Tyler, C. J., Duangdao, D. M., Grupke, S. L., Helton, D. R., Leonard, C. S. and Civelli, O. (2005) Urotensin II acts as a modulator of mesopontine cholinergic neurons. Brain Res. 1059, 139-148
41. Huitron-Resendiz, S., Kristensen, M. P., Sanchez-Alavez, M., Clark, S. D., Grupke, S. L., Tyler, C., Suzuki, C., Nothacker, H. P., Civelli, O., Criado, J. R. et al. (2005) Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J. Neurosci. 25, 5465-5474
42. MacVicar, B. A. and Tse, F. W. (1988) Norepinephrine and cyclic adenosine 3′:5′-cyclic monophosphate enhance a nifedipine-sensitive calcium current in cultured rat astrocytes. Glia 1, 359-365
43. Elshourbagy, N. A., Douglas, S. A., Shabon, U., Harrison, S., Duddy, G., Sechler, J. L., Ao, Z., Maleeff, B. E., Naselsky, D., Disa, J. and Aiyar, N. V. (2002) Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br. J. Pharmacol. 136, 9-22
44. Saetrum Opgaard, O., Nothacker, H., Ehlert, F. J. and Krause, D. N. (2000) Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur. J. Pharmacol. 406, 265-271
45. Brailoiu, E., Brailoiu, G. C., Miyamoto, M. D. and Dun, N. J. (2003) The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminals. Br. J. Pharmacol. 138, 1580-1588
46. Douglas, S. A., Naselsky, D., Ao, Z., Disa, J., Herold, C. L., Lynch, F. and Aiyar, N. V. (2004) Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. Br. J. Pharmacol. 142, 921-932
47. Hermans, E. (2003) Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol. Ther. 99, 25-44
48. Perez-Reyes, E. (2003) Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 83, 117-161
49. 2+ channel subtypes in cultured astrocytes. Glia 41, 347-353
50. Fern, R. (1998) Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. J. Neurosci. 18, 7232-7243
51. 2+ mobilization patterns. Science 284, 1527-1530
52. Itoh, T., Seki, N., Suzuki, S., Ito, S., Kajikuri, J. and Kuriyama, H. (1992) Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J. Physiol. 451, 307-328
53. 2 and proteins: interactions, organization, and information flow. Annu. Rev. Biophys. Biomol. Struct. 31, 151-175
54. Qi, J. S., Minor, L. K., Smith, C., Hu, B., Yang, J., Andrade-Gordon, P. and Damiano, B. (2005) Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors. Peptides 26, 683-690 (Pubitemid 40326887)
55. Wymann, M. P., Bjorklof, K., Calvez, R., Finan, P., Thomast, M., Trifilieff, A., Barbier, M., Altruda, F., Hirsch, E. and Laffargue, M. (2003) Phosphoinositide 3-kinase γ : a key modulator in inflammation and allergy. Biochem. Soc. Trans. 31, 275-280
56. Gao, S., Shah, A., Oh, Y. B., Park, W. H. and Kim, S. H. (2009) Urotensin II stimulates high frequency-induced ANP secretion via PLC-PI 3K-PKC pathway. Peptides 30, 1874-1881
57. Proulx, C. D., Holleran, B. J., Lavigne, P., Esher, E., Guillemette, G. and Leduc, R. (2008) Biological properties and functional determinants of the urotensin II receptor. Peptides 29, 691-699
58. Sofroniew, M. V. (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638-647
59. Shi, L., Ding, W., Li, D., Wang, Z., Jiang, H., Zhang, J. and Tang, C. (2006) Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells. Atherosclerosis 188, 260-264 (Pubitemid 44313921)